Skip to content
Screener

Emergent Biosolutions EBS Proceeds from disposals of property, plant and equipment

Proceeds from disposals of property, plant and equipment at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0-100%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$0
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Opko Health logo
Opko HealthOPK

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%
Total assets$1.1B-21.2%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$229.19M-47.4%
Enterprise value$676.49M-19.5%
P/S0.3×-0.2×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net cash provided by operating activities22.395.2
Investing Activities
Purchases of property, plant and equipment(4.5)(6.5)
Proceeds from sale of property, plant and equipment0.238.2
Milestone payment from prior asset acquisition(50.4)
Milestone proceeds from prior asset divestiture50.0
Purchase of convertible note receivable(5.0)
Net cash provided by (used in) investing activities(54.7)76.7

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Emergent Biosolutions's proceeds from disposals of property, plant and equipment?
Emergent Biosolutions (EBS) reported proceeds from disposals of property, plant and equipment of $200K in Q2 2026.
How has Emergent Biosolutions's proceeds from disposals of property, plant and equipment changed year-over-year?
Emergent Biosolutions's proceeds from disposals of property, plant and equipment increased by 100.0% year-over-year, from $100K to $200K.
What does proceeds from disposals of property, plant and equipment mean?
Proceeds from disposals of property, plant and equipment

Ask your AI about Emergent Biosolutions's proceeds from disposals of property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude